{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T14:09:53Z","timestamp":1791641393507,"version":"4.3.4"},"reference-count":127,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["mdconsult.com","theclinics.com","pediatric.theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pediatric Clinics of North America"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.pcl.2014.09.010","type":"journal-article","created":{"date-parts":[[2014,11,28]],"date-time":"2014-11-28T03:21:56Z","timestamp":1417144916000},"page":"139-165","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":94,"title":["Pediatric Lymphomas and Histiocytic Disorders of Childhood"],"prefix":"10.1016","volume":"62","author":[{"given":"Carl E.","family":"Allen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kara M.","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine M.","family":"Bollard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.pcl.2014.09.010_bib1","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1182\/blood-2010-04-278796","article-title":"Morbidity and mortality in long-term survivors of Hodgkin lymphoma: a report from the Childhood Cancer Survivor Study","volume":"117","author":"Castellino","year":"2011","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.pcl.2014.09.010_bib2","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1002\/1097-0142(19950415)75:8<2186::AID-CNCR2820750825>3.0.CO;2-F","article-title":"Incidence of cancer in children in the United States","volume":"75","author":"Gurney","year":"1995","journal-title":"Cancer"},{"issue":"19","key":"10.1016\/j.pcl.2014.09.010_bib3","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1056\/NEJM199605093341906","article-title":"Non-Hodgkin's lymphoma in childhood","volume":"334","author":"Sandlund","year":"1996","journal-title":"N\u00a0Engl J Med"},{"issue":"12","key":"10.1016\/j.pcl.2014.09.010_bib4","doi-asserted-by":"crossref","first-page":"4384","DOI":"10.1182\/blood-2008-07-077982","article-title":"Classification of lymphoid neoplasms: the microscope as a tool for disease discovery","volume":"112","author":"Jaffe","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.pcl.2014.09.010_bib5","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","first-page":"343","article-title":"Post transplant lymphoproliferative disorders","author":"Swerdlow","year":"2008"},{"issue":"3","key":"10.1016\/j.pcl.2014.09.010_bib6","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/pbc.22047","article-title":"Sporadic childhood Burkitt lymphoma incidence in the United States during 1992-2005","volume":"53","author":"Mbulaiteye","year":"2009","journal-title":"Pediatr Blood Cancer"},{"issue":"4","key":"10.1016\/j.pcl.2014.09.010_bib7","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1182\/blood-2008-01-136465","article-title":"Molecular profiling of pediatric mature B-cell lymphoma treated in population-based prospective clinical trials","volume":"112","author":"Klapper","year":"2008","journal-title":"Blood"},{"issue":"23","key":"10.1016\/j.pcl.2014.09.010_bib8","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1056\/NEJMoa055759","article-title":"Molecular diagnosis of Burkitt's lymphoma","volume":"354","author":"Dave","year":"2006","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.pcl.2014.09.010_bib9","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1309\/C1PP15P7CDB8UY39","article-title":"Clinicopathologic findings in high-grade B-cell lymphomas with typical Burkitt morphologic features but lacking the MYC translocation","volume":"128","author":"Sevilla","year":"2007","journal-title":"Am J Clin Pathol"},{"issue":"3","key":"10.1016\/j.pcl.2014.09.010_bib10","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1182\/blood-2004-03-0973","article-title":"The impact of the methotrexate administration schedule and dose in the treatment of children and adolescents with B-cell neoplasms: a report of the BFM Group Study NHL-BFM95","volume":"105","author":"Woessmann","year":"2005","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.pcl.2014.09.010_bib11","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1365-2141.2008.06988.x","article-title":"Recent advances in the understanding and management of diffuse large B-cell lymphoma in children","volume":"142","author":"Reiter","year":"2008","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.pcl.2014.09.010_bib12","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1365-2141.2005.05735.x","article-title":"The impact of age and gender on biology, clinical features and treatment outcome of non-Hodgkin lymphoma in childhood and adolescence","volume":"131","author":"Burkhardt","year":"2005","journal-title":"Br J Haematol"},{"issue":"2","key":"10.1016\/j.pcl.2014.09.010_bib13","doi-asserted-by":"crossref","first-page":"262","DOI":"10.3324\/haematol.2010.030809","article-title":"Clinical, pathological and genetic features of primary mediastinal large B-cell lymphomas and mediastinal gray zone lymphomas in children","volume":"96","author":"Oschlies","year":"2011","journal-title":"Haematologica"},{"issue":"12","key":"10.1016\/j.pcl.2014.09.010_bib14","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.1182\/blood-2003-06-1841","article-title":"The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma","volume":"102","author":"Savage","year":"2003","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.pcl.2014.09.010_bib15","doi-asserted-by":"crossref","first-page":"4047","DOI":"10.1182\/blood-2005-10-4213","article-title":"Diffuse large B-cell lymphoma in pediatric patients belongs predominantly to the germinal-center type B-cell lymphomas: a clinicopathologic analysis of cases included in the German BFM (Berlin-Frankfurt-Munster) Multicenter Trial","volume":"107","author":"Oschlies","year":"2006","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.pcl.2014.09.010_bib16","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/sj.bmt.1703806","article-title":"Post-transplant lymphoproliferative disorder: a review","volume":"31","author":"Loren","year":"2003","journal-title":"Bone Marrow Transplant"},{"issue":"12","key":"10.1016\/j.pcl.2014.09.010_bib17","doi-asserted-by":"crossref","first-page":"5496","DOI":"10.1182\/blood-2008-01-134270","article-title":"ALK- anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the International Peripheral T-Cell Lymphoma Project","volume":"111","author":"Savage","year":"2008","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.pcl.2014.09.010_bib18","first-page":"332","article-title":"Classification, staging and end results of treatment of childhood non-Hodgkin's lymphomas: dissimilarities from lymphomas in adults","volume":"7","author":"Murphy","year":"1980","journal-title":"Semin Oncol"},{"issue":"2","key":"10.1016\/j.pcl.2014.09.010_bib19","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/S0022-3468(97)90197-4","article-title":"Pulmonary function is compromised in children with mediastinal lymphoma","volume":"32","author":"King","year":"1997","journal-title":"J\u00a0Pediatr Surg"},{"issue":"6","key":"10.1016\/j.pcl.2014.09.010_bib20","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S0022-3468(85)80049-X","article-title":"Life-threatening airway obstruction as a complication to the management of mediastinal masses in children","volume":"20","author":"Azizkhan","year":"1985","journal-title":"J\u00a0Pediatr Surg"},{"issue":"4","key":"10.1016\/j.pcl.2014.09.010_bib21","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1111\/j.1365-2141.2010.08143.x","article-title":"Recommendations for the evaluation of risk and prophylaxis of tumour lysis syndrome (TLS) in adults and children with malignant diseases: an expert TLS panel consensus","volume":"149","author":"Cairo","year":"2010","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1016\/j.pcl.2014.09.010_bib22","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/bjh.12542","article-title":"Rasburicase in the prevention of laboratory\/clinical tumour lysis syndrome in children with advanced mature B-NHL: a Children's Oncology Group Report","volume":"163","author":"Galardy","year":"2013","journal-title":"Br J Haematol"},{"issue":"4","key":"10.1016\/j.pcl.2014.09.010_bib23","doi-asserted-by":"crossref","first-page":"737","DOI":"10.3109\/10428194.2012.727416","article-title":"Value of (18)F-fluoro-2-deoxy-D-glucose positron emission tomography\/computed tomography scan versus diagnostic contrast computed tomography in initial staging of pediatric patients with lymphoma","volume":"54","author":"Cheng","year":"2013","journal-title":"Leuk Lymphoma"},{"issue":"3","key":"10.1016\/j.pcl.2014.09.010_bib24","doi-asserted-by":"crossref","first-page":"253","DOI":"10.3109\/08880018.2013.834400","article-title":"Pediatric Burkitt's lymphoma and diffuse B-cell lymphoma: are surveillance scans required?","volume":"31","author":"Eissa","year":"2014","journal-title":"Pediatr Hematol Oncol"},{"issue":"1","key":"10.1016\/j.pcl.2014.09.010_bib25","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1200\/JCO.1989.7.1.92","article-title":"Similar efficacy of 6 and 18 months of therapy with four drugs (COMP) for localized non-Hodgkin's lymphoma of children: a report from the Childrens Cancer Study Group","volume":"7","author":"Meadows","year":"1989","journal-title":"J\u00a0Clin Oncol"},{"issue":"18","key":"10.1016\/j.pcl.2014.09.010_bib26","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1056\/NEJM199710303371802","article-title":"Treatment of children and young adults with early-stage non-Hodgkin's lymphoma","volume":"337","author":"Link","year":"1997","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.pcl.2014.09.010_bib27","doi-asserted-by":"crossref","first-page":"758","DOI":"10.3324\/haematol.2011.056531","article-title":"A\u00a0Cancer and Leukemia Group B multi-center study of DA-EPOCH-rituximab in untreated diffuse large B-cell lymphoma with analysis of outcome by molecular subtype","volume":"97","author":"Wilson","year":"2012","journal-title":"Haematologica"},{"issue":"19","key":"10.1016\/j.pcl.2014.09.010_bib28","doi-asserted-by":"crossref","first-page":"3115","DOI":"10.1200\/JCO.2009.26.6791","article-title":"Phase II window study on rituximab in newly diagnosed pediatric mature B-cell non-Hodgkin's lymphoma and Burkitt leukemia","volume":"28","author":"Meinhardt","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.pcl.2014.09.010_bib29","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1038\/leu.2012.255","article-title":"Rituximab and FAB\/LMB 96 chemotherapy in children with Stage III\/IV B-cell Non-Hodgkin lymphoma: a Children's Oncology Group report","volume":"27","author":"Goldman","year":"2013","journal-title":"Leukemia"},{"issue":"7","key":"10.1016\/j.pcl.2014.09.010_bib30","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1182\/blood-2006-07-036673","article-title":"Results of the randomized international FAB\/LMB96 trial for intermediate risk B-cell non-Hodgkin lymphoma in children and adolescents: it is possible to reduce treatment for the early responding patients","volume":"109","author":"Patte","year":"2007","journal-title":"Blood"},{"issue":"15","key":"10.1016\/j.pcl.2014.09.010_bib31","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1056\/NEJMoa1214561","article-title":"Dose-adjusted EPOCH-rituximab therapy in primary mediastinal B-cell lymphoma","volume":"368","author":"Dunleavy","year":"2013","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.pcl.2014.09.010_bib32","first-page":"283","article-title":"Therapy in primary mediastinal B-cell lymphoma","volume":"369","author":"Wilson","year":"2013","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.pcl.2014.09.010_bib33","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/pbc.21817","article-title":"Intensive chemotherapy for systemic anaplastic large cell lymphoma in children and adolescents: final results of Children's Cancer Group Study 5941","volume":"52","author":"Lowe","year":"2009","journal-title":"Pediatr Blood Cancer"},{"issue":"3","key":"10.1016\/j.pcl.2014.09.010_bib34","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1182\/blood-2007-07-100958","article-title":"Prognostic factors in childhood anaplastic large cell lymphoma: results of a large European intergroup study","volume":"111","author":"Le Deley","year":"2008","journal-title":"Blood"},{"issue":"30","key":"10.1016\/j.pcl.2014.09.010_bib35","doi-asserted-by":"crossref","first-page":"5056","DOI":"10.1200\/JCO.2008.20.1764","article-title":"Single-drug vinblastine as salvage treatment for refractory or relapsed anaplastic large-cell lymphoma: a report from the French Society of Pediatric Oncology","volume":"27","author":"Brugieres","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.pcl.2014.09.010_bib36","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.25187","article-title":"Advanced stage anaplastic large cell lymphoma in children and adolescents: results of ANHL0131, a randomized phase III trial of APO versus a modified regimen with vinblastine: A report from the children's oncology group","author":"Alexander","year":"2014","journal-title":"Pediatr Blood Cancer"},{"issue":"25","key":"10.1016\/j.pcl.2014.09.010_bib37","doi-asserted-by":"crossref","first-page":"3987","DOI":"10.1200\/JCO.2010.28.5999","article-title":"Vinblastine in children and adolescents with high-risk anaplastic large-cell lymphoma: results of the randomized ALCL99-vinblastine trial","volume":"28","author":"Le Deley","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"issue":"7","key":"10.1016\/j.pcl.2014.09.010_bib38","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1002\/pbc.22940","article-title":"Safety assessment of intensive induction therapy in childhood anaplastic large cell lymphoma: report of the ALCL99 randomised trial","volume":"56","author":"Wrobel","year":"2011","journal-title":"Pediatr Blood Cancer"},{"issue":"18","key":"10.1016\/j.pcl.2014.09.010_bib39","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1200\/JCO.2011.38.0402","article-title":"Brentuximab vedotin (SGN-35) in patients with relapsed or refractory systemic anaplastic large-cell lymphoma: results of a phase II study","volume":"30","author":"Pro","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"issue":"Suppl 15","key":"10.1016\/j.pcl.2014.09.010_bib40","first-page":"6","article-title":"Efficacy of crizotinib in children with relapsed\/refractory ALK-driven tumors including anaplastic large cell lymphoma and neuroblastoma: a Children's Oncology Group phase I consortium study","volume":"30","author":"Mosse","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"issue":"27","key":"10.1016\/j.pcl.2014.09.010_bib41","doi-asserted-by":"crossref","first-page":"6481","DOI":"10.1200\/JCO.2005.08.074","article-title":"Low-dose chemotherapy for Epstein-Barr virus-positive post-transplantation lymphoproliferative disease in children after solid organ transplantation","volume":"23","author":"Gross","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"issue":"26","key":"10.1016\/j.pcl.2014.09.010_bib42","doi-asserted-by":"crossref","first-page":"5113","DOI":"10.1182\/blood-2013-02-486324","article-title":"Multicenter study of banked third-party virus-specific T cells to treat severe viral infections after hematopoietic stem cell transplantation","volume":"121","author":"Leen","year":"2013","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.pcl.2014.09.010_bib43","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1182\/blood-2005-06-2508","article-title":"Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001","volume":"107","author":"Morton","year":"2006","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.pcl.2014.09.010_bib44","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1084\/jem.184.4.1495","article-title":"Hodgkin and Reed-Sternberg cells in Hodgkin's disease represent the outgrowth of a dominant tumor clone derived from (crippled) germinal center B cells","volume":"184","author":"Kanzler","year":"1996","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.pcl.2014.09.010_bib45","series-title":"Classification of tumours of haematopoietic and lymphoid tissues","first-page":"342","author":"Swerdlow","year":"2008"},{"issue":"6","key":"10.1016\/j.pcl.2014.09.010_bib46","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1002\/pbc.24423","article-title":"Children's Oncology Group's 2013 blueprint for research: Hodgkin lymphoma","volume":"60","author":"Kelly","year":"2013","journal-title":"Pediatr Blood Cancer"},{"issue":"11","key":"10.1016\/j.pcl.2014.09.010_bib47","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1097\/01.MP.0000093627.51090.3F","article-title":"Expression of B-cell markers in classical Hodgkin lymphoma: a tissue microarray analysis of 330 cases","volume":"16","author":"Tzankov","year":"2003","journal-title":"Mod Pathol"},{"issue":"1","key":"10.1016\/j.pcl.2014.09.010_bib48","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0360-3016(94)90143-0","article-title":"Hodgkin's disease in the very young","volume":"28","author":"Cleary","year":"1994","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.1016\/j.pcl.2014.09.010_bib49","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.arcmed.2014.06.001","article-title":"Prevalence and prognostic significance of Epstein-Barr virus infection in classical Hodgkin's lymphoma: a meta-analysis","volume":"45","author":"Lee","year":"2014","journal-title":"Arch Med Res"},{"issue":"3","key":"10.1016\/j.pcl.2014.09.010_bib50","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/bjh.12055","article-title":"Nodular lymphocyte predominant Hodgkin lymphoma in children and adolescents\u2013a comprehensive review of biology, clinical course and treatment options","volume":"159","author":"Shankar","year":"2012","journal-title":"Br J Haematol"},{"issue":"26","key":"10.1016\/j.pcl.2014.09.010_bib51","doi-asserted-by":"crossref","first-page":"4246","DOI":"10.1182\/blood-2013-07-515825","article-title":"The prognostic impact of variant histology in nodular lymphocyte-predominant Hodgkin lymphoma: a report from the German Hodgkin Study Group (GHSG)","volume":"122","author":"Hartmann","year":"2013","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.pcl.2014.09.010_bib52","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/cncr.24819","article-title":"Nodular, lymphocyte-predominant Hodgkin lymphoma: a long-term study and analysis of transformation to diffuse large B-cell lymphoma in a cohort of 164 patients from the Adult Lymphoma Study Group","volume":"116","author":"Biasoli","year":"2010","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.pcl.2014.09.010_bib53","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1097\/PAS.0000000000000107","article-title":"EBV may be expressed in the LP cells of nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) in both children and adults","volume":"38","author":"Huppmann","year":"2014","journal-title":"Am J Surg Pathol"},{"issue":"12","key":"10.1016\/j.pcl.2014.09.010_bib54","doi-asserted-by":"crossref","first-page":"3483","DOI":"10.1182\/blood-2004-04-1311","article-title":"Results of a prospective randomized clinical trial of doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) followed by radiation therapy (RT) versus ABVD alone for stages I, II, and IIIA nonbulky Hodgkin disease","volume":"104","author":"Straus","year":"2004","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.pcl.2014.09.010_bib55","doi-asserted-by":"crossref","first-page":"3786","DOI":"10.1182\/blood-2006-05-024109","article-title":"Hodgkin lymphoma and immunodeficiency in persons with HIV\/AIDS","volume":"108","author":"Biggar","year":"2006","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.pcl.2014.09.010_bib56","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1093\/annonc\/mdt533","article-title":"Systematic review and meta-analysis on the diagnostic performance of FDG-PET\/CT in detecting bone marrow involvement in newly diagnosed Hodgkin lymphoma: is bone marrow biopsy still necessary?","volume":"25","author":"Adams","year":"2014","journal-title":"Ann Oncol"},{"issue":"11","key":"10.1016\/j.pcl.2014.09.010_bib57","first-page":"1860","article-title":"Report of the Committee on Hodgkin's disease staging classification","volume":"31","author":"Carbone","year":"1971","journal-title":"Cancer Res"},{"issue":"11","key":"10.1016\/j.pcl.2014.09.010_bib58","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1200\/JCO.1989.7.11.1630","article-title":"Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting","volume":"7","author":"Lister","year":"1989","journal-title":"J\u00a0Clin Oncol"},{"issue":"18","key":"10.1016\/j.pcl.2014.09.010_bib59","doi-asserted-by":"crossref","first-page":"3765","DOI":"10.1200\/JCO.2002.12.007","article-title":"Randomized comparison of low-dose involved-field radiotherapy and no radiotherapy for children with Hodgkin's disease who achieve a complete response to chemotherapy","volume":"20","author":"Nachman","year":"2002","journal-title":"J\u00a0Clin Oncol"},{"issue":"23","key":"10.1016\/j.pcl.2014.09.010_bib60","doi-asserted-by":"crossref","first-page":"3680","DOI":"10.1200\/JCO.2009.26.9381","article-title":"Procarbazine-free OEPA-COPDAC chemotherapy in boys and standard OPPA-COPP in girls have comparable effectiveness in pediatric Hodgkin's lymphoma: the GPOH-HD-2002 study","volume":"28","author":"Mauz-Korholz","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"issue":"6","key":"10.1016\/j.pcl.2014.09.010_bib61","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s00431-013-1993-8","article-title":"The utility of FDG PET in diagnosis and follow-up of lymphoma in childhood","volume":"172","author":"Sioka","year":"2013","journal-title":"Eur J Pediatr"},{"issue":"11","key":"10.1016\/j.pcl.2014.09.010_bib62","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1097\/01.mph.0000243648.66734.eb","article-title":"Routine use of PET scans after completion of therapy in pediatric Hodgkin disease results in a high false positive rate","volume":"28","author":"Levine","year":"2006","journal-title":"J\u00a0Pediatr Hematol Oncol"},{"key":"10.1016\/j.pcl.2014.09.010_bib63","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2013.52.5410","article-title":"Dose-Intensive Response-Based Chemotherapy and Radiation Therapy for Children and Adolescents With Newly Diagnosed Intermediate-Risk Hodgkin Lymphoma: A Report From the Children's Oncology Group Study AHOD0031","author":"Friedman","year":"2014","journal-title":"Schwartz J Clin Oncol"},{"issue":"3","key":"10.1016\/j.pcl.2014.09.010_bib64","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.semradonc.2007.02.009","article-title":"Pediatric Hodgkin lymphoma: maximizing efficacy and minimizing toxicity","volume":"17","author":"Hodgson","year":"2007","journal-title":"Semin Radiat Oncol"},{"issue":"19","key":"10.1016\/j.pcl.2014.09.010_bib65","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1056\/NEJMoa1002965","article-title":"Brentuximab vedotin (SGN-35) for relapsed CD30-positive lymphomas","volume":"363","author":"Younes","year":"2010","journal-title":"N\u00a0Engl J Med"},{"issue":"13","key":"10.1016\/j.pcl.2014.09.010_bib66","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1016\/S1470-2045(13)70501-1","article-title":"Brentuximab vedotin combined with ABVD or AVD for patients with newly diagnosed Hodgkin's lymphoma: a phase 1, open-label, dose-escalation study","volume":"14","author":"Younes","year":"2013","journal-title":"Lancet Oncol"},{"issue":"4","key":"10.1016\/j.pcl.2014.09.010_bib67","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1002\/pbc.24851","article-title":"Stratification of treatment intensity in relapsed pediatric Hodgkin lymphoma","volume":"61","author":"Harker-Murray","year":"2014","journal-title":"Pediatr Blood Cancer"},{"issue":"16","key":"10.1016\/j.pcl.2014.09.010_bib68","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1016\/S0959-8049(03)00672-5","article-title":"Langerhans cell histiocytosis in adults. Report from the International Registry of the Histiocyte Society","volume":"39","author":"Arico","year":"2003","journal-title":"Eur J Cancer"},{"issue":"1","key":"10.1016\/j.pcl.2014.09.010_bib69","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/pbc.21498","article-title":"Descriptive epidemiology of childhood Langerhans cell histiocytosis in France, 2000-2004","volume":"51","author":"Guyot-Goubin","year":"2008","journal-title":"Pediatr Blood Cancer"},{"issue":"5","key":"10.1016\/j.pcl.2014.09.010_bib70","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1136\/adc.2008.144527","article-title":"Incidence and clinical features of Langerhans cell histiocytosis in the UK and Ireland","volume":"94","author":"Salotti","year":"2009","journal-title":"Arch Dis Child"},{"issue":"1","key":"10.1016\/j.pcl.2014.09.010_bib71","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1002\/pbc.21504","article-title":"Incidence of Langerhans cell histiocytosis in children: a population-based study","volume":"51","author":"Stalemark","year":"2008","journal-title":"Pediatr Blood Cancer"},{"issue":"4","key":"10.1016\/j.pcl.2014.09.010_bib72","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1046\/j.1365-2141.1999.01777.x","article-title":"Familial clustering of Langerhans cell histiocytosis","volume":"107","author":"Arico","year":"1999","journal-title":"Br J Haematol"},{"issue":"5","key":"10.1016\/j.pcl.2014.09.010_bib73","first-page":"365","article-title":"Histiocytosis X histogenetic arguments for a Langerhans cell origin","volume":"18","author":"Nezelof","year":"1973","journal-title":"Biomedicine"},{"issue":"8","key":"10.1016\/j.pcl.2014.09.010_bib74","doi-asserted-by":"crossref","first-page":"4557","DOI":"10.4049\/jimmunol.0902336","article-title":"Cell-specific gene expression in Langerhans cell histiocytosis lesions reveals a distinct profile compared with epidermal Langerhans cells","volume":"184","author":"Allen","year":"2010","journal-title":"J\u00a0Immunol"},{"issue":"11","key":"10.1016\/j.pcl.2014.09.010_bib75","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1182\/blood-2010-04-279083","article-title":"Recurrent BRAF mutations in Langerhans cell histiocytosis","volume":"116","author":"Badalian-Very","year":"2010","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.pcl.2014.09.010_bib76","doi-asserted-by":"crossref","first-page":"e33891","DOI":"10.1371\/journal.pone.0033891","article-title":"B-RAF mutant alleles associated with Langerhans cell histiocytosis, a granulomatous pediatric disease","volume":"7","author":"Satoh","year":"2012","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.pcl.2014.09.010_bib77","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.1182\/blood-2012-06-429597","article-title":"BRAFV600E mutant protein is expressed in cells of variable maturation in Langerhans cell histiocytosis","volume":"120","author":"Sahm","year":"2012","journal-title":"Blood"},{"issue":"13","key":"10.1016\/j.pcl.2014.09.010_bib78","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1182\/blood-2012-05-430140","article-title":"High prevalence of BRAF V600E mutations in Erdheim-Chester disease but not in other non-Langerhans cell histiocytoses","volume":"120","author":"Haroche","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.pcl.2014.09.010_bib79","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1084\/jem.20130977","article-title":"BRAF-V600E expression in precursor versus differentiated dendritic cells defines clinically distinct LCH risk groups","volume":"211","author":"Berres","year":"2014","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.pcl.2014.09.010_bib80","unstructured":"Simko SJ, Garmezy B, Abhyankar H, et\u00a0al. Differentiating skin-limited and multisystem Langerhans cell histiocytosis. J Pediatr, in press."},{"key":"10.1016\/j.pcl.2014.09.010_bib81","doi-asserted-by":"crossref","first-page":"5006","DOI":"10.1182\/blood-2012-09-455774","article-title":"Therapy prolongation improves outcome in multi-system Langerhans cell histiocytosis","volume":"121","author":"Gadner","year":"2013","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.pcl.2014.09.010_bib82","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.jpeds.2008.05.002","article-title":"Reactivations in multisystem Langerhans cell histiocytosis: data of the international LCH registry","volume":"153","author":"Minkov","year":"2008","journal-title":"J\u00a0Pediatr"},{"issue":"5","key":"10.1016\/j.pcl.2014.09.010_bib83","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1002\/pbc.20021","article-title":"Permanent consequences in Langerhans cell histiocytosis patients: a pilot study from the Histiocyte Society-Late Effects Study Group","volume":"42","author":"Haupt","year":"2004","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"10.1016\/j.pcl.2014.09.010_bib84","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/pbc.21782","article-title":"Comparison of FDG-PET scans to conventional radiography and bone scans in management of Langerhans cell histiocytosis","volume":"52","author":"Phillips","year":"2009","journal-title":"Pediatr Blood Cancer"},{"issue":"8","key":"10.1016\/j.pcl.2014.09.010_bib85","doi-asserted-by":"crossref","first-page":"e43257","DOI":"10.1371\/journal.pone.0043257","article-title":"Optimal therapy for adults with Langerhans cell histiocytosis bone lesions","volume":"7","author":"Cantu","year":"2012","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.pcl.2014.09.010_bib86","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1002\/pbc.21668","article-title":"Clofarabine in refractory Langerhans cell histiocytosis","volume":"51","author":"Rodriguez-Galindo","year":"2008","journal-title":"Pediatr Blood Cancer"},{"issue":"6","key":"10.1016\/j.pcl.2014.09.010_bib87","doi-asserted-by":"crossref","first-page":"E19","DOI":"10.1002\/pbc.24436","article-title":"Clofarabine salvage therapy for refractory high-risk langerhans cell histiocytosis","volume":"60","author":"Abraham","year":"2013","journal-title":"Pediatr Blood Cancer"},{"issue":"3","key":"10.1016\/j.pcl.2014.09.010_bib88","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1002\/pbc.24772","article-title":"Clofarabine salvage therapy in refractory multifocal histiocytic disorders, including Langerhans cell histiocytosis, juvenile xanthogranuloma and Rosai-Dorfman disease","volume":"61","author":"Simko","year":"2014","journal-title":"Pediatr Blood Cancer"},{"issue":"9","key":"10.1016\/j.pcl.2014.09.010_bib89","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1182\/blood-2012-07-446286","article-title":"Dramatic efficacy of vemurafenib in both multisystemic and refractory Erdheim-Chester disease and Langerhans cell histiocytosis harboring the BRAF V600E mutation","volume":"121","author":"Haroche","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.pcl.2014.09.010_bib90","first-page":"83","article-title":"Targeting oncogenic BRAF in human cancer","volume":"355","author":"Pratilas","year":"2012","journal-title":"Curr Top Microbiol Immunol"},{"issue":"1","key":"10.1016\/j.pcl.2014.09.010_bib91","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/01.pas.0000147395.01229.06","article-title":"Juvenile xanthogranuloma in childhood and adolescence: a clinicopathologic study of 129 patients from the kiel pediatric tumor registry","volume":"29","author":"Janssen","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pcl.2014.09.010_bib92","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/B978-0-12-417028-5.00005-3","article-title":"Pathological consequence of misguided dendritic cell differentiation in histiocytic diseases","volume":"120","author":"Berres","year":"2013","journal-title":"Adv Immunol"},{"issue":"5","key":"10.1016\/j.pcl.2014.09.010_bib93","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1097\/00000478-200305000-00003","article-title":"Juvenile xanthogranulomas in the first two decades of life: a clinicopathologic study of 174 cases with cutaneous and extracutaneous manifestations","volume":"27","author":"Dehner","year":"2003","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"10.1016\/j.pcl.2014.09.010_bib94","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0022-3476(96)70247-0","article-title":"Juvenile xanthogranuloma: forms of systemic disease and their clinical implications","volume":"129","author":"Freyer","year":"1996","journal-title":"J\u00a0Pediatr"},{"issue":"1","key":"10.1016\/j.pcl.2014.09.010_bib95","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/pbc.21523","article-title":"Treatment of juvenile xanthogranuloma","volume":"51","author":"Stover","year":"2008","journal-title":"Pediatr Blood Cancer"},{"issue":"3","key":"10.1016\/j.pcl.2014.09.010_bib96","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1002\/pbc.21830","article-title":"Successful treatment of central nervous system juvenile xanthogranulomatosis with cladribine","volume":"52","author":"Rajendra","year":"2009","journal-title":"Pediatr Blood Cancer"},{"issue":"4","key":"10.1016\/j.pcl.2014.09.010_bib97","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1182\/blood-2014-03-561381","article-title":"Consensus guidelines for the diagnosis and clinical management of Erdheim-Chester disease","volume":"124","author":"Diamond","year":"2014","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.pcl.2014.09.010_bib98","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/(SICI)1096-911X(199709)29:3<157::AID-MPO1>3.0.CO;2-C","article-title":"Contemporary classification of histiocytic disorders. The WHO Committee On Histiocytic\/Reticulum Cell Proliferations. Reclassification Working Group of the Histiocyte Society","volume":"29","author":"Favara","year":"1997","journal-title":"Med Pediatr Oncol"},{"issue":"6","key":"10.1016\/j.pcl.2014.09.010_bib99","first-page":"386","article-title":"Langerhans cell sarcoma arising from chronic lymphocytic lymphoma\/small lymphocytic leukemia: lineage analysis and BRAF V600E Mutation Study","volume":"5","author":"Chen","year":"2013","journal-title":"N\u00a0Am J Med Sci"},{"issue":"7","key":"10.1016\/j.pcl.2014.09.010_bib100","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1097\/PAS.0b013e318283099f","article-title":"Clonally related follicular lymphomas and Langerhans cell neoplasms: expanding the spectrum of transdifferentiation","volume":"37","author":"West","year":"2013","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"10.1016\/j.pcl.2014.09.010_bib101","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/modpathol.2013.181","article-title":"Langerhans cell histiocytosis in acute leukemias of ambiguous or myeloid lineage in adult patients: support for a possible clonal relationship","volume":"27","author":"Yohe","year":"2014","journal-title":"Mod Pathol"},{"issue":"1","key":"10.1016\/j.pcl.2014.09.010_bib102","first-page":"63","article-title":"Sinus histiocytosis with massive lymphadenopathy. A newly recognized benign clinicopathological entity","volume":"87","author":"Rosai","year":"1969","journal-title":"Arch Pathol"},{"key":"10.1016\/j.pcl.2014.09.010_bib103","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1182\/asheducation-2004.1.283","article-title":"Atypical cellular disorders","author":"McClain","year":"2004","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"15","key":"10.1016\/j.pcl.2014.09.010_bib104","doi-asserted-by":"crossref","first-page":"4041","DOI":"10.1182\/blood-2011-03-278127","article-title":"How I treat hemophagocytic lymphohistiocytosis","volume":"118","author":"Jordan","year":"2011","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.pcl.2014.09.010_bib105","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.yexcr.2014.03.014","article-title":"Pathophysiology and spectrum of diseases caused by defects in lymphocyte cytotoxicity","volume":"325","author":"Meeths","year":"2014","journal-title":"Exp Cell Res"},{"issue":"9","key":"10.1016\/j.pcl.2014.09.010_bib106","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1002\/art.23734","article-title":"Macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis is associated with MUNC13-4 polymorphisms","volume":"58","author":"Zhang","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"22","key":"10.1016\/j.pcl.2014.09.010_bib107","doi-asserted-by":"crossref","first-page":"5794","DOI":"10.1182\/blood-2011-07-370148","article-title":"Hypomorphic mutations in PRF1, MUNC13-4, and STXBP2 are associated with adult-onset familial HLH","volume":"118","author":"Zhang","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.pcl.2014.09.010_bib108","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1182\/blood-2014-05-573105","article-title":"Synergistic defects of different molecules in the cytotoxic pathway lead to clinical familial hemophagocytic lymphohistiocytosis","volume":"124","author":"Zhang","year":"2014","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.pcl.2014.09.010_bib109","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/pbc.21039","article-title":"HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis","volume":"48","author":"Henter","year":"2007","journal-title":"Pediatr Blood Cancer"},{"issue":"7","key":"10.1016\/j.pcl.2014.09.010_bib110","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1182\/blood-2002-01-0172","article-title":"Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation","volume":"100","author":"Henter","year":"2002","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.pcl.2014.09.010_bib111","doi-asserted-by":"crossref","first-page":"2838","DOI":"10.1182\/blood-2007-05-091280","article-title":"Complete responses of relapsed lymphoma following genetic modification of tumor-antigen presenting cells and T-lymphocyte transfer","volume":"110","author":"Bollard","year":"2007","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.pcl.2014.09.010_bib112","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1182\/blood-2009-08-239186","article-title":"Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients","volume":"115","author":"Heslop","year":"2010","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.pcl.2014.09.010_bib113","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1200\/JCO.2013.51.5304","article-title":"Sustained complete responses in patients with lymphoma receiving autologous cytotoxic T lymphocytes targeting Epstein-Barr virus latent membrane proteins","volume":"32","author":"Bollard","year":"2014","journal-title":"J\u00a0Clin Oncol"},{"issue":"7","key":"10.1016\/j.pcl.2014.09.010_bib114","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1182\/blood-2006-07-036665","article-title":"Results of a randomized international study of high-risk central nervous system B non-Hodgkin lymphoma and B acute lymphoblastic leukemia in children and adolescents","volume":"109","author":"Cairo","year":"2007","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.pcl.2014.09.010_bib115","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1111\/j.1365-2141.2008.07144.x","article-title":"Excellent survival following two courses of COPAD chemotherapy in children and adolescents with resected localized B-cell non-Hodgkin's lymphoma: results of the FAB\/LMB 96 international study","volume":"141","author":"Gerrard","year":"2008","journal-title":"Br J Haematol"},{"issue":"12","key":"10.1016\/j.pcl.2014.09.010_bib116","doi-asserted-by":"crossref","first-page":"3699","DOI":"10.1182\/blood.V97.12.3699","article-title":"Short-pulse B-non-Hodgkin lymphoma-type chemotherapy is efficacious treatment for pediatric anaplastic large cell lymphoma: a report of the Berlin-Frankfurt-Munster Group Trial NHL-BFM 90","volume":"97","author":"Seidemann","year":"2001","journal-title":"Blood"},{"issue":"21","key":"10.1016\/j.pcl.2014.09.010_bib117","doi-asserted-by":"crossref","first-page":"5616","DOI":"10.1182\/blood-2010-12-324012","article-title":"Limited stage I disease is not necessarily indicative of an excellent prognosis in childhood anaplastic large cell lymphoma","volume":"117","author":"Attarbaschi","year":"2011","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.pcl.2014.09.010_bib118","first-page":"3294","article-title":"Improved treatment results in childhood B-cell neoplasms with tailored intensification of therapy: a report of the\u00a0Berlin-Frankfurt-Munster Group Trial NHL-BFM 90","volume":"94","author":"Reiter","year":"1999","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.pcl.2014.09.010_bib119","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1200\/JCO.2000.18.7.1500","article-title":"Localized childhood Hodgkin's disease: response-adapted chemotherapy with etoposide, bleomycin, vinblastine, and prednisone before low-dose radiation therapy-results of the French Society of Pediatric Oncology Study MDH90","volume":"18","author":"Landman-Parker","year":"2000","journal-title":"J\u00a0Clin Oncol"},{"issue":"12","key":"10.1016\/j.pcl.2014.09.010_bib120","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1200\/JCO.2012.45.3266","article-title":"Treatment of children and adolescents with Hodgkin lymphoma without radiotherapy for patients in complete remission after chemotherapy: final results of the multinational trial GPOH-HD95","volume":"31","author":"Dorffel","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"issue":"3","key":"10.1016\/j.pcl.2014.09.010_bib121","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1200\/JCO.2006.08.4772","article-title":"Final results of a prospective clinical trial with VAMP and low-dose involved-field radiation for children with low-risk Hodgkin's disease","volume":"25","author":"Donaldson","year":"2007","journal-title":"J\u00a0Clin Oncol"},{"issue":"24","key":"10.1016\/j.pcl.2014.09.010_bib122","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1001\/jama.2012.5847","article-title":"Association between radiotherapy vs no radiotherapy based on early response to VAMP chemotherapy and survival among children with favorable-risk Hodgkin lymphoma","volume":"307","author":"Metzger","year":"2012","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.pcl.2014.09.010_bib123","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1002\/pbc.24279","article-title":"Response-dependent and reduced treatment in lower risk Hodgkin lymphoma in children and adolescents, results of P9426: a report from the Children's Oncology Group","volume":"59","author":"Tebbi","year":"2012","journal-title":"Pediatr Blood Cancer"},{"issue":"9","key":"10.1016\/j.pcl.2014.09.010_bib124","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1182\/blood-2010-05-285379","article-title":"BEACOPP chemotherapy is a highly effective regimen in children and adolescents with high-risk Hodgkin lymphoma: a report from the Children's Oncology Group","volume":"117","author":"Kelly","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.pcl.2014.09.010_bib125","series-title":"Histiocytic disorders of children and adults. Basic Science, Clinical Features, and Therapy","first-page":"14","article-title":"The diagnostic histopathology of Lanerhans cell histiocytosis","author":"Jaffe","year":"2005"},{"issue":"6","key":"10.1016\/j.pcl.2014.09.010_bib126","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s10024-004-3027-z","article-title":"Langerin (CD207) staining in normal pediatric tissues, reactive lymph nodes, and childhood histiocytic disorders","volume":"7","author":"Chikwava","year":"2004","journal-title":"Pediatr Dev Pathol"},{"issue":"4","key":"10.1016\/j.pcl.2014.09.010_bib127","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1097\/PAS.0b013e31815b212b","article-title":"Immunohistochemical expression of Langerin in Langerhans cell histiocytosis and non-Langerhans cell histiocytic disorders","volume":"32","author":"Lau","year":"2008","journal-title":"Am J Surg Pathol"}],"container-title":["Pediatric Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031395514001898?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031395514001898?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,27]],"date-time":"2020-08-27T08:31:41Z","timestamp":1598517101000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031395514001898"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":127,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["S0031395514001898"],"URL":"https:\/\/doi.org\/10.1016\/j.pcl.2014.09.010","relation":{},"ISSN":["0031-3955"],"issn-type":[{"value":"0031-3955","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pediatric Lymphomas and Histiocytic Disorders of Childhood","name":"articletitle","label":"Article Title"},{"value":"Pediatric Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pcl.2014.09.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}